2022
DOI: 10.3390/cells11030406
|View full text |Cite
|
Sign up to set email alerts
|

New Insights into the Mechanisms of Chaperon-Mediated Autophagy and Implications for Kidney Diseases

Abstract: Chaperone-mediated autophagy (CMA) is a separate type of lysosomal proteolysis, characterized by its selectivity of substrate proteins and direct translocation into lysosomes. Recent studies have declared the involvement of CMA in a variety of physiologic and pathologic situations involving the kidney, and it has emerged as a potential target for the treatment of kidney diseases. The role of CMA in kidney diseases is context-dependent and appears reciprocally with macroautophagy. Among the renal resident cells… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 109 publications
0
4
0
Order By: Relevance
“…Hsp70s could recognize and bind a KFERQ-like pentapeptide motif in the substrate proteins, making them the key proteins required for chaperone-mediated autophagy (CMA) to deliver cargo to lysosomes. CMA degrades target soluble proteins in a selective manner and is the predominant form of autophagy in the tubular system ( 32 , 33 ). Hsp70s would regulate autophagic flux through the ubiquitin-mediated proteasome system and also the autophagosome–lysosome fusion system ( 34 ).…”
Section: Discussionmentioning
confidence: 99%
“…Hsp70s could recognize and bind a KFERQ-like pentapeptide motif in the substrate proteins, making them the key proteins required for chaperone-mediated autophagy (CMA) to deliver cargo to lysosomes. CMA degrades target soluble proteins in a selective manner and is the predominant form of autophagy in the tubular system ( 32 , 33 ). Hsp70s would regulate autophagic flux through the ubiquitin-mediated proteasome system and also the autophagosome–lysosome fusion system ( 34 ).…”
Section: Discussionmentioning
confidence: 99%
“…Since oxidative stress is commonly involved in various chronic diseases, Nrf2 could be a therapeutic target for these chronic diseases [ 60 ]. Moreover, CMA failure has also been reported in patients with chronic liver and kidney diseases [ 61 , 62 ]. It is expected that D-cysteine can be used as a novel Nrf2 and CMA activator selective for the cerebellum, liver, and kidneys via hydrogen sulfide production.…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, dysfunction of CMA as a consequence of some diseases can aggravate the pathology. That is the case in the involvement of suppressed CMA activity in several pathologic conditions in the kidney [106]. The accumulation of CMA substrates by impaired CMA in the renal cortex during acute diabetes mellitus might also be associated with the development of diabetic-induced renal hypertrophy [106,107].…”
Section: Aging-associated Diseases and Other Pathologiesmentioning
confidence: 98%